Second Tumors in PTEN Mutation-Positive Patients: Are They Recurrences or New Primaries?
Among more than 2,000 patients with an invasive cancer, more than 5% had a mutation in PTEN and almost half of these patients had a second malignancy. This observation has implications for patients with breast, endometrial and thyroid cancer, and those with known PTEN mutations.